150 related articles for article (PubMed ID: 21417601)
1. Non-coated multiparticulate matrix systems for colon targeting.
Krenzlin S; Siepmann F; Wils D; Guerin-Deremaux L; Flament MP; Siepmann J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1150-9. PubMed ID: 21417601
[TBL] [Abstract][Full Text] [Related]
2. Novel polymeric film coatings for colon targeting: Drug release from coated pellets.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Flament MP; Dubreuil L; Desreumaux P; Siepmann J
Eur J Pharm Sci; 2009 Jun; 37(3-4):427-33. PubMed ID: 19491034
[TBL] [Abstract][Full Text] [Related]
3. Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.
Karrout Y; Neut C; Siepmann F; Wils D; Ravaux P; Deremaux L; Flament MP; Dubreuil L; Lemdani M; Desreumaux P; Siepmann J
J Pharm Pharmacol; 2010 Dec; 62(12):1676-84. PubMed ID: 21054393
[TBL] [Abstract][Full Text] [Related]
4. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
Peerapattana J; Otsuka K; Otsuka M
Biomed Mater Eng; 2004; 14(3):293-301. PubMed ID: 15299241
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
[TBL] [Abstract][Full Text] [Related]
7. Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance.
Nieto-Bobadilla MS; Siepmann F; Djouina M; Dubuquoy L; Tesse N; Willart JF; Dubreuil L; Siepmann J; Neut C
Eur J Pharm Biopharm; 2015 Oct; 96():152-61. PubMed ID: 26209123
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
Al-Zoubi NM; AlKhatib HS; Obeidat WM
Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
[TBL] [Abstract][Full Text] [Related]
9. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
10. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and examination of the vitro releasing of pH-dependent kuijiekang tablet for colon-specific delivery].
Li RZ; Liao HW; Chen FY
Zhong Yao Cai; 2007 Aug; 30(8):1025-7. PubMed ID: 18074860
[TBL] [Abstract][Full Text] [Related]
12. Novel polymeric film coatings for colon targeting: how to adjust desired membrane properties.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Desreumaux P; Siepmann J
Int J Pharm; 2009 Apr; 371(1-2):64-70. PubMed ID: 19135511
[TBL] [Abstract][Full Text] [Related]
13. Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease.
Bautzová T; Rabišková M; Lamprecht A
Drug Dev Ind Pharm; 2011 Sep; 37(9):1100-9. PubMed ID: 21417610
[TBL] [Abstract][Full Text] [Related]
14. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
Talukder RM; Fassihi R
J Pharm Pharmacol; 2008 Oct; 60(10):1297-303. PubMed ID: 18812022
[TBL] [Abstract][Full Text] [Related]
15. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
16. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
Vemula SK
Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ethylcellulose: starch-based film coatings for colon targeting.
Karrout Y; Neut C; Wils D; Siepmann F; Deremaux L; Desreumaux P; Siepmann J
Drug Dev Ind Pharm; 2009 Oct; 35(10):1190-200. PubMed ID: 19555251
[TBL] [Abstract][Full Text] [Related]
18. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
Zambito Y; Baggiani A; Carelli V; Serafini MF; Di Colo G
J Control Release; 2005 Feb; 102(3):669-77. PubMed ID: 15681088
[TBL] [Abstract][Full Text] [Related]
19. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
Vemula SK
AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
[TBL] [Abstract][Full Text] [Related]
20. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
Kadam VD; Gattani SG
Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
